Optimized Bee Venom Peptide Melittin Shows Promise Against Ulcerative Colitis in Mice
Chemically stabilized melittin, a bee venom peptide, demonstrated significant anti-ulcerative colitis effects in mice through enhanced stability and reduced toxicity compared to the natural peptide.
Quick Facts
What This Study Found
Stability-optimized melittin variants maintained anti-inflammatory activity while resisting protease degradation, significantly reducing ulcerative colitis severity in a mouse model.
Key Numbers
PCJ-675 showed improved proteolytic stability compared to native melittin. Tested in DSS-induced ulcerative colitis mouse model. Administered orally. Reduced colon shortening and suppressed inflammation markers (TLR4/NF-kB pathway).
How They Did This
Animal study involving chemical synthesis and optimization of melittin variants for stability, followed by protease resistance testing and evaluation in a mouse ulcerative colitis model for efficacy and safety.
Why This Research Matters
Ulcerative colitis affects millions worldwide, and current treatments have limited efficacy and significant side effects. Bee venom peptides are a rich source of anti-inflammatory compounds, but their therapeutic development has been limited by poor stability. This study shows that chemical optimization can overcome this barrier.
The Bigger Picture
This study demonstrates a general strategy for advancing venom-derived peptides into drug candidates. The stability-optimization approach could be applied to many other bioactive peptides from venoms and other natural sources that have been shelved due to poor pharmacokinetic properties.
What This Study Doesn't Tell Us
Animal study only — mouse UC model may not fully predict human response; toxicity profile of modified melittin needs thorough assessment; long-term safety unknown; delivery route and dosing for clinical use not optimized; cost of peptide synthesis and modification may be high.
Questions This Raises
- ?What is the optimal delivery route for stabilized melittin in UC — oral, rectal, or systemic?
- ?How does the modified peptide's safety profile compare to established UC treatments?
- ?Could the stability-optimization approach be applied to other venom-derived anti-inflammatory peptides?
Trust & Context
- Key Stat:
- Stability-optimized Chemical modifications made melittin resistant to protease degradation while maintaining anti-colitis activity
- Evidence Grade:
- Preclinical animal study with peptide engineering component. Demonstrates proof-of-concept but is early in the drug development pipeline.
- Study Age:
- Published in 2025, reflecting growing interest in venom-derived peptide therapeutics.
- Original Title:
- Efficient synthesis, stability-guided optimization and anti-ulcerative colitis evaluation of bee venom peptide melittin.
- Published In:
- Bioorganic & medicinal chemistry letters, 128, 130357 (2025)
- Authors:
- Pang, Cheng-Jian, Yao, Jing-Fang, Lv, Qiu-Lan, Zhang, Li-Ze, Yu, Qian-Yao, Zeng, Li, Qi, Yun-Kun
- Database ID:
- RPEP-12938
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could bee venom really treat inflammatory bowel disease?
Melittin, the main component of bee venom, has strong anti-inflammatory properties. The challenge has been that it breaks down too quickly in the body to be useful as a drug. This study solved that by chemically modifying the peptide to make it more stable while keeping its healing properties.
Is it safe to use venom-derived medications?
The therapeutic peptide is a purified, modified version of just one component of bee venom — not the whole venom. Many approved drugs are derived from venoms (like the blood pressure drug captopril from snake venom). Careful modification and testing ensure the beneficial effects are kept while reducing toxicity.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-12938APA
Pang, Cheng-Jian; Yao, Jing-Fang; Lv, Qiu-Lan; Zhang, Li-Ze; Yu, Qian-Yao; Zeng, Li; Qi, Yun-Kun. (2025). Efficient synthesis, stability-guided optimization and anti-ulcerative colitis evaluation of bee venom peptide melittin.. Bioorganic & medicinal chemistry letters, 128, 130357. https://doi.org/10.1016/j.bmcl.2025.130357
MLA
Pang, Cheng-Jian, et al. "Efficient synthesis, stability-guided optimization and anti-ulcerative colitis evaluation of bee venom peptide melittin.." Bioorganic & medicinal chemistry letters, 2025. https://doi.org/10.1016/j.bmcl.2025.130357
RethinkPeptides
RethinkPeptides Research Database. "Efficient synthesis, stability-guided optimization and anti-..." RPEP-12938. Retrieved from https://rethinkpeptides.com/research/pang-2025-efficient-synthesis-stabilityguided-optimization
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.